ADCs (ANTIBODY DRUG CONJUGATES)
The growth of Antibody Drug Conjugates (ADCs) has created a critical need for dependable supply of small-molecule intermediates such as linkers, payload precursors, and conjugation scaffolds. LMS supports ADC innovators with precision synthesis, scalable production, and high-containment operations designed for sensitive chemistry.
WHY LMS
- Proven experience in complex, high-precision small-molecule synthesis
- Reliable, compliant supply for fast-growing ADC programs
- Collaborative engagement with innovators and CDMOs
- Transparent execution and predictable timelines
FAQs
What ADC components does LMS supply?
Does LMS manufacture cytotoxic payloads?
Can LMS develop custom ADC intermediates?
What scale of ADC intermediates can LMS handle?
How does LMS ensure quality for ADC components?
Close